News

Nplate may be considered as second line treatment for adult non-splenectomized immune thrombocytopenic purpura patients where surgery is contra-indicated. According to the company, Nplate, the first and only

During this development work, Orexo will continue negotiations to enter into an appropriate global exclusive licensing agreement including the whole of Orexo’s Ox17 program and related intellectual property.

The purchase agreement contemplated the acquisition of the operating subsidiaries of the company and Andover Medical by Medical Solutions Management (MSMT) in exchange for capital stock of MSMT.

According to the company, customers will see an everyday shelf price of about $20 for each of the two Accu-Chek blood glucose meter care kits wherever Accu-Chek products

The Lenetix PloidYX maternal blood test is claimed to be the most accurate and comprehensive test developed for the detection of fetal aneuploidies, the presence of extra chromosomes,

De Novo Ventures of Palo Alto, California, led this round as well as SynergEyes’s series B round. Bio-Star Private Equity Fund joined series A and B investors: Alloy

The series A funding round will be used to continue the development and marketing of Linkage Biosciences’s line of diagnostic products. The molecular diagnostics technologies and innovations will

With the appointment of Mr Bowerman, Rick Pauls is stepping down as president and CEO of DiaMedica. Mr Pauls will continue to serve as chairman of the board

The ATS 3f aortic bioprosthesis is a next generation stentless pericardial aortic tissue valve. According to the company, the primary benefit of the ATS 3f aortic bioprosthesis is